These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .
Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
The efficacy of oxprenolol ( Trasicor ) and propranolol in controlling anxiety was compared in a double-blind study of patients with anxiety and tension .  Efficacy was assessed by the investigator with the aid of a psychiatric rating scale consisting of 19 items , bythe patients using visual analogue scales , and by the investigator 's and the patients ' over-all assessment s. Tolerance to the drugs was evaluated by over-all assessment and by means of a checklist of signs and symptoms which emerged during treatment . Little difference in the efficacy of the two drugs was observed . Both were effective in the treatment of anxiety and tension . In general , oxprenolol was significantly better tolerated than propranolol . Evidence of the intrinsic sympathomimetic activity of oxprenolol emerged during the course of the study or , alternatively , evidence that propranolol had a greater cardiac-depressant effect
These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .